Overview:

Summary

GlobalData’s new report, “Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global neurostimulation devices market. The report provides market landscape, competitive landscape and market trends information on the neurostimulation devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Cortical Stimulators.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within neurostimulation devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, St. Jude Medical, Boston Scientific Corporation and Cyberonics.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the neurostimulation devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the neurostimulation devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global neurostimulation devices market and the factors shaping it."

Companies Mentioned

Medtronic, Inc.
St. Jude Medical
Boston Scientific Corporation
Cyberonics, Inc.

1 Table of contents 3
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction and Overview 9
2.1 GlobalData Report Guidance 9
3 Disease Overview 10
3.1 Disease Overview - Chronic Pain 10
3.1.1 Introduction 10
3.1.2 Causes of Chronic Pain 11
3.1.3 Signs and Symptoms 11
3.1.4 Treatment 11
3.1.5 Epidemiology 12
3.2 Disease Overview - Parkinson’s Disease 12
3.2.1 Introduction 12
3.2.2 Causes of Parkinson’s Disease 12
3.2.3 Signs and Symptoms 13
3.2.4 Treatment 14
3.2.5 Epidemiology 14
3.3 Disease Overview - Epilepsy 15
3.3.1 Introduction 15
3.3.2 Causes of Epilepsy 15
3.3.3 Signs and Symptoms 15
3.3.4 Treatment 15
3.3.5 Epidemiology 16
4 Neurostimulation Devices Overview 17
4.1 Technology Overview 17
4.1.1 Introduction 17
4.1.2 Types of Neurostimulation Systems 17
4.1.3 Applications of Neurostimulation Devices 18
4.1.4 Neurostimulation Devices, Market Segmentation 18
5 Neurostimulation Devices - Global Market Characterization 20
5.1 Neurostimulation Devices Market, Global, Revenue ($m), Historic, 2003−2010 20
5.2 Neurostimulation Devices Market, Global, Revenue ($m), Forecast, 2010−2017 21
5.3 Neurostimulation Device, Key Trends 22
5.3.1 Application of Neurostimulation Technology for the Treatment of New Indications 22
5.3.2 Neurostimulation Devices Market is Witnessing Increasing Innovation 24
5.3.3 Technological Advances such as Increased Battery Life have led to an Increase in the Adoption of Neurostimulation Devices 24
5.4 Neurostimulation Devices, Market Dynamics 25
5.4.1 Market Drivers 25
5.4.2 Market Restraints 31
5.5 Neurostimulation Devices, Key Opportunities and Unmet Needs 32
5.5.1 Opportunities 32
5.5.2 Unmet Needs 33
6 Global Neurostimulation Devices Market: Segment Analysis 34
6.1 Spinal Cord Stimulators, Market Characterization 34
6.1.1 Spinal Cord Stimulators Market, Revenue ($m), Historic, 2003-2010 34
6.1.2 Spinal Cord Stimulators Market, Revenue ($m), Forecast, 2010-2017 35
6.1.3 Spinal Cord Stimulators, Market Dynamics 36
6.2 Deep Brain Stimulators, Market Characterization 37
6.2.1 Deep Brain Stimulators Market, Revenue ($m), Historic, 2003 − 2010 37
6.2.2 Deep Brain Stimulators Market, Revenue ($m), Forecast, 2010-2017 38
6.2.3 Deep Brain Stimulators, Market Dynamics 39
6.3 Sacral Nerve Stimulators, Market Characterization 40
6.3.1 Sacral Nerve Stimulators Market, Revenue ($m), Historic, 2003-2010 40
6.3.2 Sacral Nerve Stimulators Market, Revenue ($m), Forecast, 2010-2017 41
6.3.3 Sacral Nerve Stimulators, Market Dynamics 42
6.4 Vagus Nerve Stimulators, Market Characterization 43
6.4.1 Vagus Nerve Stimulators Market, Revenue ($m), Historic, 2003-2010 43
6.4.2 Vagus Nerve Stimulators Market, Revenue ($m), Forecast, 2010-2017 44
6.4.3 Vagus Nerve Stimulators, Market Dynamics 45
6.5 Cortical Stimulators, Market Characterization 46
6.5.1 Cortical Stimulators Market, Revenue ($m), Historic, 2003-2010 46
6.5.2 Cortical Stimulators Market, Revenues ($m), Forecast, 2010-2017 47
6.5.3 Cortical Stimulators, Market Dynamics 47
7 Neurostimulation Devices Market, by Country, Revenue ($m), 2003-2017 48
7.1 Neurostimulation Devices Market, The US, Revenue ($m), By Segment, Historic, 2003-2010 48
7.2 Neurostimulation Devices Market, The US, Revenue ($m), By Segment, Forecast, 2010-2017 49
7.3 Neurostimulation Devices Market, Canada, Revenue ($m), By Segment, Historic, 2003-2010 50
7.4 Neurostimulation Devices Market, Canada, Revenue ($m), By Segment, Forecast, 2010–2017 51
7.5 Neurostimulation Devices Market, The UK, Revenue ($m), By Segment, Historic, 2003–2010 52
7.6 Neurostimulation Devices Market, The UK Revenue ($m), By Segment, Forecast, 2010–2017 53
7.7 Neurostimulation Devices Market, Germany, Revenue ($m), By Segment, Historic, 2003–2010 54
7.8 Neurostimulation Devices Market, Germany, Revenue ($m), By Segment, Forecast, 2010–2017 55
7.9 Neurostimulation Devices Market, France, Revenue ($m), By Segment, Historic, 2003-2010 56
7.10 Neurostimulation Devices Market, France, Revenue ($m), By Segment, Forecast, 2010–2017 57
7.11 Neurostimulation Devices Market, Italy, Revenue ($m), By Segment, Historic, 2003–2010 58
7.12 Neurostimulation Devices Market, Italy, Revenue ($m), By Segment, Forecast, 2010–2017 59
7.13 Neurostimulation Devices Market, Spain, Revenue ($m), By Segment, Historic, 2003-2010 60
7.14 Neurostimulation Devices Market, Spain, Revenue ($m), By Segment, Forecast, 2010-2017 61
7.15 Neurostimulation Devices Market, Japan, Revenue ($m), By Segment, Historic, 2003-2010 62
7.16 Neurostimulation Devices Market, Japan, Revenue ($m), By Segment, Forecast, 2010-2017 63
7.17 Neurostimulation Devices Market, China, Revenue ($m), By Segment, Historic, 2003-2010 64
7.18 Neurostimulation Devices Market, China, Revenue ($m), By Segment, Forecast, 2010-2017 65
7.19 Neurostimulation Devices Market, India, Revenue ($m), By Segment, Historic, 2003-2010 66
7.20 Neurostimulation Devices Market, India, Revenue ($m), By Segment, Forecast, 2010-2017 67
7.21 Neurostimulation Devices Market, Australia, Revenue ($m), By Segment, Historic, 2003-2010 68
7.22 Neurostimulation Devices Market, Australia, Revenue ($m), By Segment, Forecast, 2010-2017 69
7.23 Neurostimulation Devices Market, Brazil, Revenue ($m), By Segment, Historic, 2003-2010 70
7.24 Neurostimulation Devices Market, Brazil, Revenue ($m), By Segment, Forecast, 2010-2017 71
8 Neurostimulation Devices Market - Competitive Landscape 72
8.1 Neurostimulation Devices Market, Key Company Share (%), 2010 72
8.2 Neurostimulation Devices Market, Key Market Participants 73
8.2.1 Medtronic, Inc. 73
8.2.2 St. Jude Medical 78
8.2.3 Boston Scientific Corporation 81
8.2.4 Cyberonics, Inc. 83
9 Neurostimulation Devices Market - Key Marketed Products 86
9.1 PrimeAdvanced Neurostimulator (Medtronic, Inc.) 86
9.1.1 Product Description 86
9.1.2 Product Features 86
9.2 Activa Portfolio of DBS systems (Medtronic, Inc.) 86
9.2.1 Product Description 86
9.2.2 Product Features 87
9.3 Precision Plus SCS System (Boston Scientific Corporation) 87
9.3.1 Product Description 87
9.3.2 Product Features 87
9.4 Brio Rechargeable IPG (St. Jude Medical) 88
9.4.1 Product Description 88
9.4.2 Product Features 88
9.5 Eon-Mini Rechargeable IPG system (St. Jude Medical) 88
9.5.1 Product Description 88
9.5.2 Product Features 88
10 Neurostimulation Devices Market - Strategic Pipeline Assessment 89
10.1 Pipeline Products Assessment for Neurostimulation Devices by Development Stage, Global, 2010   89
10.2 Neurostimulation Devices - Profiles of Key Pipeline Products Under Clinical Development 89
10.2.1 Active Implantable Device- Parkinson’s Disease 89
10.2.2 Balance System 89
10.2.3 Biocompatible Neural Electrode 90
10.2.4 Bioness Battery Powered Microstimulator 90
10.2.5 CardioFit System 92
10.2.6 CR Brain 93
10.2.7 Deep TMS H System 93
10.2.8 Enterra-Obesity 99
10.2.9 Intercept Epilepsy Control System 100
10.2.10 Ischemic Stroke System 101
10.2.11 Libra Deep Brain Stimulation System - Depression 102
10.2.12 Neurostep 103
10.2.13 Noninvasive Device - Sensory Enhancement Technology 105
10.2.14 Occipital Nerve Stimulation System 106
10.2.15 Pain Therapy Device 108
10.2.16 PrimeADVANCED- Heart Failure 109
10.2.17 Resolve Stimulator and Proximity Electrode 110
10.2.18 RNS System 112
10.2.19 ScyFIX 700 Therapy 115
10.2.20 Transcranial Magnetic Stimulation Device 118
10.2.21 Traxon Spinal Cord Repair Stimulation System 119
10.2.22 Vercise DBS System 120
11 Neurostimulation Devices Market: Deals Landscape 121
11.1 Neurostimulation Devices Market, M&A Landscape 122
11.1.1 Key Acquisitions 122
11.2 Neurostimulation Devices Market, Partnership Deals 124
11.2.1 Key Partnership Deals 124
12 Appendix 126
12.1 Market Definitions 126
12.1.1 Neurostimulation Devices 126
12.2 Acronyms 127
12.3 Sources 128
12.4 Research Methodology 129
12.4.1 Secondary Research 129
12.4.2 Primary Research 129
12.4.3 Models 130
12.4.4 Forecasts 130
12.4.5 Expert Panel 130
12.5 GlobalData Consulting 130
12.6 Contact Us 131
12.7 Disclaimer 131"

1.1 List of Tables
Table 1: Deep Brain Stimulators, Key Marketed Products 18
Table 2: Spinal Cord Stimulators, Key Marketed Products 19
Table 3: Neurostimulation Devices Market, Global, Revenue ($m), 2003-2010 20
Table 4: Neurostimulation Devices Market, Global, Revenue ($m), 2010-2017 21
Table 5: Pipeline Products In-Development for New Indications 23
Table 6: Population Aged 65 Years and Over, Global, %, 2010 26
Table 7: Neurostimulation Devices Market, Global, PE/VC Deals, 2006−2010 28
Table 8: Neurostimulation Devices, Global, Average Selling Price ($), 2010 31
Table 9: Spinal Cord Stimulators Market, Global, Revenue ($m), 2003-2010 34
Table 10: Spinal Cord Stimulators Market, Global, Revenue ($m), 2010-2017 35
Table 11: Deep Brain Stimulators Market, Global, Revenue ($m), 2003-2010 37
Table 12: Deep Brain Stimulators Market, Global, Revenue ($m), 2010-2017 38
Table 13: DBS Pipeline Products 39
Table 14: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2003-2010 40
Table 15: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2010-2017 41
Table 16: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2003-2010 43
Table 17: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2010-2017 44
Table 18: Cortical Stimulators Market, Global, Revenue ($m), 2003-2010 46
Table 19: Cortical Stimulators Market, Global, Revenue ($m), 2010-2017 47
Table 20: Neurostimulation Devices Market, The US, Revenue ($m), 2003-2010 48
Table 21: Neurostimulation Devices Market, The US, Revenue ($m), 2010-2017 49
Table 22: Neurostimulation Devices Market, Canada, Revenue ($m), 2003-2010 50
Table 23: Neurostimulation Devices Market, Canada, Revenue ($m), 2010-2017 51
Table 24: Neurostimulation Devices Market, The UK, Revenue ($m), 2003-2010 52
Table 25: Neurostimulation Devices Market, The UK, Revenue ($m), 2010-2017 53
Table 26: Neurostimulation Devices Market, Germany, Revenue ($m), 2003-2010 54
Table 27: Neurostimulation Devices Market, Germany, Revenue ($m), 2010-2017 55
Table 28: Neurostimulation Devices Market, France, Revenue ($m), 2003-2010 56
Table 29: Neurostimulation Devices Market, France, Revenue ($m), 2010-2017 57
Table 30: Neurostimulation Devices Market, Italy, Revenue ($m), 2003-2010 58
Table 31: Neurostimulation Devices Market, Italy, Revenue ($m), 2010-2017 59
Table 32: Neurostimulation Devices Market, Spain, Revenue ($m), 2003-2010 60
Table 33: Neurostimulation Devices Market, Spain, Revenue ($m), 2010-2017 61
Table 34: Neurostimulation Devices Market, Japan, Revenue ($m), 2003-2010 62
Table 35: Neurostimulation Devices Market, Japan, Revenue ($m), 2010-2017 63
Table 36: Neurostimulation Devices Market, China, Revenue ($m), 2003-2010 64
Table 37: Neurostimulation Devices Market, China, Revenue ($m), 2010-2017 65
Table 38: Neurostimulation Devices Market, India, Revenue ($m), 2003-2010 66
Table 39: Neurostimulation Devices Market, India, Revenue ($m), 2010-2017 67
Table 40: Neurostimulation Devices Market, Australia, Revenue ($m), 2003-2010 68
Table 41: Neurostimulation Devices Market, Australia, Revenue ($m), 2010-2017 69
Table 42: Neurostimulation Devices Market, Brazil, Revenue ($m), 2003-2010 70
Table 43: Neurostimulation Devices Market, Brazil, Revenue ($m), 2010-2017 71
Table 44: Global Neurostimulation Devices Market, Company Share, Revenue ($m), 2010 72
Table 45: Medtronic, Neurostimulators, Marketed Products 73
Table 46: Medtronic, Neurostimulators, Pipeline Products 74
Table 47: St. Jude Medical, Neurostimulators, Marketed Products 78
Table 48: St. Jude Medical, Neurostimulators, Pipeline Products 78
Table 49: Boston Scientific, Neurostimulators, Pipeline Products 81
Table 50: Cyberonics, Neurostimulators, Marketed Products 83
Table 51: Cyberonics, Neurostimulators, Pipeline Products 83
Table 52: PrimeAdvanced Neurostimulator, Features and Benefits 86
Table 53: Activa DBS systems, Features and Benefits 87
Table 54: Precision Plus SCS system, Features and Benefits 87
Table 55: Brio Rechargeable IPG, Features and Benefits 88
Table 56: Eon Mini Rechargeable IPG system, Features and Benefits 88
Table 57: Balance System, Clinical Trial 90
Table 58: Bioness Battery Powered Microstimulator, Clinical Trial 91
Table 59: CardioFit System, Clinical Trial 92
Table 60: CardioFit System, Clinical Trial 93
Table 61: Deep TMS H System, Clinical Trial 94
Table 62: Deep TMS H System, Clinical Trial 95
Table 63: Deep TMS H System, Clinical Trial 96
Table 64: Deep TMS H System, Clinical Trial 97
Table 65: Deep TMS H System, Clinical Trial 98
Table 66: Enterra-Obesity, Clinical Trial 99
Table 67: Intercept Epilepsy Control System, Clinical Trial 100
Table 68: Ischemic Stroke System, Clinical Trial 101
Table 69: Ischemic Stroke System, Clinical Trial 102
Table 70: Libra Deep Brain Stimulation System, Clinical Trial 103
Table 71: Neurostep, Clinical Trial 104
Table 72: Non-invasive Device - Sensory Enhancement, Clinical Trial 105
Table 73: Occipital Nerve Stimulation System, Clinical Trial 106
Table 74: Occipital Nerve Stimulation System, Clinical Trial 107
Table 75: Pain Therapy Device, Clinical Trial 108
Table 76: PrimeADVANCED-Heart Failure, Clinical Trial 109
Table 77: Resolve Stimulator and Proximity Electrode, Clinical Trial 110
Table 78: Resolve Stimulator and Proximity Electrode, Clinical Trial 111
Table 79: RNS System, Clinical Trial 112
Table 80: RNS System, Clinical Trial 113
Table 81: RNS System, Clinical Trial 114
Table 82: ScyFIX 700 Therapy, Clinical Trial 115
Table 83: ScyFIX 700 Therapy, Clinical Trial 116
Table 84: ScyFIX 700 Therapy, Clinical Trial 116
Table 85: ScyFIX 700 Therapy, Clinical Trial 117
Table 86: ScyFIX 700 Therapy, Clinical Trial 117
Table 87: Transcranial Magnetic Stimulation (TMS) Device, Clinical Trial 118
Table 88: Traxon Spinal Cord Repair Stimulation System, Clinical Trial 119
Table 89: Vercise DBS System, Clinical Trial 120
Table 90: Neurostimulation Devices Market, Global, Deals Overview, 2006-2011 121
Table 91: Neurostimulation Devices Market, Global, Partnership Landscape, 2006−2010 124"

1.2 List of Figures
Figure 1: Classification of Pain 10
Figure 2: Types of Neurostimulation Devices 18
Figure 3: Neurostimulation Devices Market, Global, Revenue ($m), 2003-2010 20
Figure 4: Neurostimulation Devices Market, Global, Revenue ($m), 2010-2017 21
Figure 5: Indications of Neurostimulation Devices 22
Figure 6: Neurostimulation Devices, Closed Loop System 24
Figure 7: Neurostimulation Devices Market, Global, PE/VC Deals, 2006−2010 28
Figure 8: Risks Associated with Neurostimulation Devices 33
Figure 9: Spinal Cord Stimulators Market, Global, Revenue ($m), 2003-2010 34
Figure 10: Spinal Cord Stimulators Market, Global, Revenue ($m), 2010-2017 35
Figure 11: Deep Brain Stimulators Market, Global, Revenue ($m), 2003-2010 37
Figure 12: Deep Brain Stimulators Market, Global, Revenue ($m), 2010-2017 38
Figure 13: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2003-2010 40
Figure 14: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2010-2017 41
Figure 15: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2003-2010 43
Figure 16: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2010-2017 44
Figure 17: Cortical Stimulators Market, Global, Revenue ($m), 2003-2010 46
Figure 18: Cortical Stimulators Market, Global, Revenue ($m), 2010-2017 47
Figure 19: Neurostimulation Devices Market, The US, Revenue ($m), 2003-2010 48
Figure 20: Neurostimulation Devices Market, The US, Revenue ($m), 2010-2017 49
Figure 21: Neurostimulation Devices Market, Canada, Revenue ($m), 2003-2010 50
Figure 22: Neurostimulation Devices Market, Canada, Revenue ($m), 2010-2017 51
Figure 23: Neurostimulation Devices Market, The UK, Revenue ($m), 2003-2010 52
Figure 24: Neurostimulation Devices Market, The UK, Revenue ($m), 2010-2017 53
Figure 25: Neurostimulation Devices Market, Germany, Revenue ($m), 2003-2010 54
Figure 26: Neurostimulation Devices Market, Germany, Revenue ($m), 2010-2017 55
Figure 27: Neurostimulation Devices Market, France, Revenue ($m), 2003-2010 56
Figure 28: Neurostimulation Devices Market, France, Revenue ($m), 2010-2017 57
Figure 29: Neurostimulation Devices Market, Italy, Revenue ($m), 2003-2010 58
Figure 30: Neurostimulation Devices Market, Italy, Revenue ($m), 2010-2017 59
Figure 31: Neurostimulation Devices Market, Spain, Revenue ($m), 2003-2010 60
Figure 32: Neurostimulation Devices Market, Spain, Revenue ($m), 2010-2017 61
Figure 33: Neurostimulation Devices Market, Japan, Revenue ($m), 2003-2010 62
Figure 34: Neurostimulation Devices Market, Japan, Revenue ($m), 2010-2017 63
Figure 35: Neurostimulation Devices Market, China, Revenue ($m), 2003-2010 64
Figure 36: Neurostimulation Devices Market, China, Revenue ($m), 2010-2017 65
Figure 37: Neurostimulation Devices Market, India, Revenue ($m), 2003-2010 66
Figure 38: Neurostimulation Devices Market, India, Revenue ($m), 2010-2017 67
Figure 39: Neurostimulation Devices Market, Australia, Revenue ($m), 2003-2010 68
Figure 40: Neurostimulation Devices Market, Australia, Revenue ($m), 2010-2017 69
Figure 41: Neurostimulation Devices Market, Brazil, Revenue ($m), 2003-2010 70
Figure 42: Neurostimulation Devices Market, Brazil, Revenue ($m), 2010-2017 71
Figure 43: Global Neurostimulation Devices Market, Company Share (%), 2010 72
Figure 44: Neurostimulation Devices Market, Medtronic, SWOT Analysis 74
Figure 45: Neurostimulation Devices Market, St. Jude Medical, SWOT Analysis 79
Figure 46: Neurostimulation Devices Market, Boston Scientific, SWOT Analysis 81
Figure 47: Neurostimulation Devices Market, Cyberonics, SWOT Analysis 84
Figure 48: Neurostimulation Devices, Pipeline Products, By Development Stage 89
Figure 49: Neurostimulation Devices Market, Global, Deals Overview, 2006-2011 121
Figure 50: Neurostimulation Devices Market, Global, M&A Landscape 122